Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
FRTX was delisted on the 18th of December, 2023.
30 hedge funds and large institutions have $7.15M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
18% more capital invested
Capital invested by funds: $6.08M → $7.15M (+$1.08M)
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
11% more funds holding
Funds holding: 27 → 30 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$789K |
| 2 |
Renaissance Technologies
New York
|
+$404K |
| 3 |
SSWM
Smith Salley Wealth Management
Greensboro,
North Carolina
|
+$306K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$91.3K |
| 5 |
TI
Telemetry Investments
New York
|
+$88.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$72K |
| 2 |
Two Sigma Investments
New York
|
-$45.1K |
| 3 |
HF
HRT Financial
New York
|
-$29K |
| 4 |
QCG
Quadrant Capital Group
Cincinnati,
Ohio
|
-$20K |
| 5 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $2K | +$164 | +4 | +6% |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $2K | +$1.97K | +48 | New |
|
|
VF
28
Virtu Financial
New York
| – | -$72K | -1,458 | Closed |
|
|
HF
29
HRT Financial
New York
| – | -$29K | -609 | Closed |
|
|
QCG
30
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$20K | -400 | Closed |
|
|
VFA
31
Valeo Financial Advisors
Carmel,
Indiana
| – | -$7K | -138 | Closed |
|
32
Bank of America
Charlotte,
North Carolina
| – | -$370 | -9 | -75% |
|
|
SIC
33
Salem Investment Counselors
Winston Salem,
North Carolina
| – | +$41 | +1 | New |
|
FRTX Hedge Fund Activity: Q2 2021 in Review
30 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q2 2021, worth a combined $7.15M — up 18% from $6.08M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new FRTX positions and 4 closed out — a net gain of 3 holders — while 7 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $789K. The largest seller was Virtu Financial, exiting entirely with an estimated $72K sold.
- 30 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q2 2021, up from 27 in Q1 2021.
- Funds reported $7.15M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q2 2021, up 18% quarter-over-quarter.
- 7 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q2 2021 and 4 closed out, a net change of +3 holders.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q2 2021 was Vanguard Group, an estimated $789K added.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q2 2021 was Virtu Financial, an estimated $72K sold.
Based on aggregated 13F filings for Q2 2021.